Company News

Gilead Sciences Inc. has agreed to pay $1.4 billion, or $20 a share, for CV Therapeutics, a manufacturer of chest pain and heart drugs. The bid tops Astellas' $16-a-share bid for CV Therapeutics, announced last January.


GSW Worldwide's Pink Tank, an agency specializing in health marketing to women, has launched a new web site: The site provides information about strategic consulting services for clients who want to reach women consumers.

You must be a registered member of MMM to post a comment.